Advertisement
more top stories »

Emory University


— Science

A good book can change your life ... and your brain

By - January 5, 2014 2 Pictures
Stories, whether fact or fiction, are at the heart of human culture. A strong narrative can resonate with your personality and experiences, and help set a framework for your future. "That book changed my life" is a cherished maxim. So can a book change your brain too? A recent study led by Emory University's Gregory Berns has demonstrated that reading a novel produces physical changes in the brain similar to those that would result from living as one or more of the characters. Read More
— Health and Wellbeing

Microneedles improve drug delivery to the back of the eye

By - July 26, 2012 3 Pictures
Researchers at the Georgia Institute of Technology and Atlanta's Emory University have developed microneedles less than a millimeter in length that can deliver drug molecules and particles to the region in the back of eye. The new technology provides an alternative to current methods which are either invasive, with drugs being injected into the center of the eye, or based on eyedrops, which are limited in their effectiveness. Read More
— Environment

HyperSolar harnesses sunlight to produce cleaner-than-clean hydrogen fuel

By - January 26, 2012 1 Picture
HyperSolar claims it is developing a zero carbon method of producing hydrogen gas from wastewater by harnessing solar energy. Hydrogen gas is a clean source of fuel in that, theoretically at least, the only waste product is water. But hydrogen gas does not occur naturally on Earth, and requires energy to create. Typically that energy comes from traditional, carbon dioxide-emitting sources, rendering hydrogen fuel rather less environmentally friendly than it has the potential to be. HyperSolar's work may mean truly clean, renewable hydrogen fuel could be a commercial reality sooner than we might have imagined. Read More
— Music

The scientific formula for predicting a hit song

By - December 27, 2011 3 Pictures
You hear a new song. Will it be a hit or a flop? Researchers from Bristol University in the U.K. say they can now tell you - well, sort of. After studying the Top 40 singles charts over the last 50 years and examining the audio characteristics for hits and flops, the team has come up with a formula as to what makes for a successful song and used it to devise software that "predicts" hits. The next step is a web app to allow budding musicians to score their own songs. Read More
— Medical

SpectroPen shines a light on tumors in real time

By - October 14, 2010 1 Picture
Statistics indicate that complete removal, or resection, of a tumor is the single most important predictor of patient survival for those with solid tumors. So, unsurprisingly, the first thing most patients want to know after surgery is whether the surgeon got everything. A new hand-held device called the SpectroPen could help surgeons provide a more definite and desirable answer by allowing them to see the edges of tumors in human patients in real time during surgery. Read More
— Medical

Dissolving microneedle patches – clean, painless, longer-lasting vaccinations

By - July 20, 2010 4 Pictures
Doctors have been using hypodermic needles for more than 150 years – but syringe vaccinations could be just about to be replaced by a simple patch you can stick on your arm with no medical supervision. The microneedle patches have an array of microscopic needles on them that penetrate the skin just deep enough to dissolve and deliver a vaccine without causing any pain. There's no sharp hazardous waste left over, they're no more expensive than a syringe, and most importantly, tests on mice are showing that microneedle vaccinations are significantly longer-lasting than deeper injections delivered by syringe. Read More
— Health and Wellbeing

Second Sight announces milestone in groundbreaking retinal implant trial

By - February 19, 2008 4 Pictures
February 20, 2008 It has to be among the most powerful examples of the miraculous potential of modern science and technology - restoring sight to the blind. Following approval from the US FDA last year, Second Sight Medical Products Inc has now announced that enrollment is complete for the first phase of clinical trials on a system that restores a basic level of sight to sufferers of retinal eye diseases. Enrollment at key European sites also underway. Ten subjects have been recruited for the Phase I trial of the second-generation electronic retinal implant known as The Argus II, which is capable of restoring rudimentary vision using an external camera and transmitter mounted in eyeglasses linked to a tiny array of 60 electrodes that are attached to the retina. Read More
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Subscribe to Gizmag's email newsletter

Advertisement